1. A Phase 2a Double-Blind Randomized Trial of REL-1017 (Esmethadone) in Patients with MDD: Analysis of Subscales from the Symptoms of Depression Questionnaire. (April 2022) Authors: Guidetti, Clotilde; Fava, Maurizio; Pani, Luca; Pappagallo, Marco; Serra, Giulia; DeMartin, Sara; Mattarei, Andrea; Manfredi, Paolo L. Journal: CNS spectrums Issue: Volume 27:Number 2(2022) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗